MUP-uPA was reported to exhibit human-like features of NASH—insulin resistance, obesity, hepatocyte ballooning, inflammation, and advanced fibrosis by 16 weeks of HFD feeding. This evidence concerns the gene PLAU and metabolic dysfunction-associated steatohepatitis.